Table 6.
Therapeutic approach in the total study population according to the medical and surgical pathways. Statistically significant differences (p-value < 0.05) between drug administration in the medical and surgical populations are highlighted in bold fonts.
| Therapeutic Approach | Total | Medical | Surgical |
|---|---|---|---|
| Oxygen or ventilation, n (%) | 548 (58.7%) | 521 (64.5%) | 27 (21.4%) |
| Crystalloids, n (%) | 106 (11.3%) | 79 (9.8%) | 27 (21.4%) |
| Colloids, n (%) | 28 (3%) | 20 (2.5%) | 8 (6.3%) |
| Glucagon or insulin, n (%) | 26 (2.8%) | 25 (3.1%) | 1 (0.8%) |
| Electric therapy, n (%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Antiseizure, n (%) | 98 (10.5%) | 96 (11.9%) | 2 (1.6%) |
| Sedatives, n (%) | 47 (5%) | 26 (3.2%) | 21 (16.7%) |
| Psychoactive drugs, n (%) | 11 (1.2%) | 11 (1.4%) | 0 (0%) |
| Antibiotics or antivirals, n (%) | 172 (18.4%) | 155 (19.2%) | 17 (13.5%) |
| Antipyretics or analgesics, n (%) | 269 (28.8%) | 233 (28.8%) | 36 (28.6%) |
| Antiemetics, n (%) | 23 (2.5%) | 17 (2.1%) | 6 (4.8%) |
| Steroids, n (%) | 260 (27.8%) | 257 (31.8%) | 3 (2.4%) |
| Drugs acting or airways, n (%) | 376 (40.2%) | 376 (46.5%) | 0 (0%) |
| Diuretics, n (%) | 12 (1.3%) | 12 (1.5%) | 0 (0%) |
| Cardioactive drugs, n (%) | 27 (2.9%) | 23 (2.8%) | 4 (3.2%) |
| Dressings, n (%) | 24 (2.6%) | 1 (0.1%) | 23 (18.3%) |